Crucell N.V.
Crucell N.V., a prominent biopharmaceutical company headquartered in the Netherlands, has established itself as a leader in the development of innovative vaccines and therapeutic proteins. Founded in 1993, Crucell has made significant strides in the industry, particularly in the fields of infectious diseases and monoclonal antibodies.
With a strong operational presence across Europe and North America, Crucell focuses on creating unique products that leverage its proprietary technologies, such as the PER.C6® cell line. This advanced platform enables the efficient production of high-quality biopharmaceuticals, setting Crucell apart in a competitive market.
Recognised for its commitment to research and development, Crucell has achieved notable milestones, including successful collaborations and partnerships that enhance its market position. The company continues to drive advancements in vaccine development, contributing to global health initiatives and improving patient outcomes.
+36 vs industry average
Crucell N.V.’s score of 74 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Crucell N.V.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Crucell N.V. yet.
Crucell N.V.'s reported carbon emissions
Crucell N.V., headquartered in the Netherlands (NL), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Johnson & Johnson, which influences its climate commitments and initiatives.
Crucell N.V. inherits its climate targets and initiatives from Johnson & Johnson, which has established Science-Based Targets Initiative (SBTi) commitments aimed at reducing greenhouse gas emissions across its operations. These targets are cascaded down to Crucell N.V. as part of its corporate family relationship.
While specific reduction targets for Crucell N.V. are not detailed, the overarching goals set by Johnson & Johnson include significant reductions in Scope 1, 2, and 3 emissions, aligning with industry standards for climate action. The company is also involved in initiatives such as the Carbon Disclosure Project (CDP) and RE100, which further demonstrate its commitment to sustainability and transparency in emissions reporting.
In summary, while Crucell N.V. does not provide specific emissions data, it is actively engaged in climate commitments through its association with Johnson & Johnson, focusing on substantial reductions in carbon emissions as part of a broader corporate sustainability strategy.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Crucell N.V.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Crucell N.V. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Johnson & Johnson
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Inherited from Johnson & JohnsonClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project